CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma
暂无分享,去创建一个
J. Sancho | A. Santoro | D. Rasco | P. Hagner | S. Carrancio | L. Ysebaert | J. López-Martín | V. Ribrag | M. Pourdehnad | A. Stoppa | C. Panizo | K. Hege | Xin-Xin Wei | C. Carpio | R. Cordoba | M. Gharibo | A. Gandhi | S. Damian